Zobrazeno 1 - 10
of 260
pro vyhledávání: '"Jean Michel Hannoun-Levi"'
Autor:
Marta Gimeno-Morales, Laura Motisi, Natalia Rodriguez-Spiteri, Fernando Martínez-Regueira, Tucker Worthington, Vratislav Strnad, Jean Michel Hannoun-Levi, Cristina Gutierrez
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 16, Iss 1, Pp 72-83 (2024)
Externí odkaz:
https://doaj.org/article/903c2edc295c4818ac11ed3210f5fcca
Autor:
Jean-Michel Hannoun-Levi, Marie-Eve Chand-Fouche, Tanguy Pace-Loscos, Mathieu Gautier, Jocelyn Gal, Renaud Schiappa, Nina Pujol
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 37, Iss , Pp 64-70 (2022)
Purpose: To report the results of the Single Fraction Early Prostate Irradiation (SiFEPI) phase 2 prospective trial. Materials/Methods: The SiFEPI trial (NCT02104362) evaluated a single fraction of high-dose rate brachytherapy (HDB) for low- (LR) and
Externí odkaz:
https://doaj.org/article/ba481b83c50843eb84967432af6eff73
Autor:
Delphine Marotte, Jocelyn Gal, Renaud Schiappa, Mathieu Gautier, Rabia Boulahssass, Marie-Eve Chand-Fouche, Jean-Michel Hannoun-Levi
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 35, Iss , Pp 104-109 (2022)
Purpose: To analyze the oncological outcome in elderly (>70 years) prostate cancer after high-dose rate brachytherapy (HDB) boost. Materials/methods: In this retrospective study, patients with intermediate (IR) and high-risk (HR) prostate cancer unde
Externí odkaz:
https://doaj.org/article/8071efa1a0ca4367b726ca8c89a6a5c1
Autor:
Nicolas Martz, Nicolas Benziane-Ouaritini, Mathieu Gautier, Isabelle Brenot-Rossi, Lucile Montagne, Naji Salem, Yohan Bodokh, Jean-Michel Hannoun-Levi
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 13, Iss 5, Pp 593-597 (2021)
The origin of penile metastases is in 70% of cases from primary pelvic cancers (genitourinary and recto-sigmoid primary tumors). The prognosis is poor and it is often associated with synchronous bone metastases at the time of diagnosis. We present th
Externí odkaz:
https://doaj.org/article/0fd9b85489504033a35246592828363a
Publikováno v:
Brachytherapy.
Publikováno v:
Clinical and Translational Radiation Oncology. 35:1-8
Autor:
Pierre-Alexis Gauci, Daniel Lam Cham Kee, Brice Thamphya, Renaud Schiappa, Jerome Delotte, Marie-Eve Chand-Fouche, Jean-Michel Hannoun-Levi
Publikováno v:
Brachytherapy. 21:273-282
To report long-term oncological and toxicity outcomes after high-dose-rate brachytherapy (HDB) followed by oncologic surgery for patients with early-stage cervical cancer.From 2005 to 2019, all patients treated with preoperative HDB at Antoine Lacass
Autor:
Jean-Pierre Gerard, Lucile Montagne, Brice Thamphya, Jerôme Doyen, Renaud Schiappa, Karene Benezery, Sophie Gourgou, Catherine Dejean, Jean-Michel Hannoun-Levi
Publikováno v:
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, Vol 33, Iss, Pp 70-76 (2022)
Clinical and Translational Radiation Oncology, Vol 33, Iss, Pp 70-76 (2022)
Highlights • Key objective: the goal provides data to evaluate the oncological risk of performing a planned- conservative strategy in selected patients presenting early T2-T3 rectal adenocarcinoma. • Knowledge generated: This propensity score ana
Autor:
Maud le Guyader, Daniel Lam Cham Kee, Mathieu Gautier, Marie-Eve Chand-Fouche, Renaud Schiappa, Brice Thamphya, Jean-Michel Hannoun-Levi
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 32, Iss, Pp 15-23 (2022)
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology
Highlights • Brachytherapy boost is a standard of care for locally advanced cervical cancer. • High-dose-rate brachytherapy (HDR-BT) boost procedure is not standardized. • The number of implants, fractions, doses and imaging differ in literatur
Autor:
Manon Kissel, Luc Ollivier, Ingrid Fumagalli, Pascal Pommier, Cyrus Chargari, Pierre Blanchard, Didier Peiffert, Jean-Michel Hannoun-Levi
Publikováno v:
Journal of Contemporary Brachytherapy. 14:501-511